H

Hyundai Bioscience Co Ltd
KOSDAQ:048410

Watchlist Manager
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Watchlist
Price: 11 250 KRW 11.39% Market Closed
Market Cap: ₩1.1T

Balance Sheet

Balance Sheet Decomposition
Hyundai Bioscience Co Ltd

Balance Sheet
Hyundai Bioscience Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2000 Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
15 375
1 581
18 136
36 676
30 016
24 434
12 043
16 975
25 708
4 120
5 251
4 168
2 080
1 958
2 169
11 914
9 743
4 851
3 162
5 555
19 215
9 189
2 732
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
3
2
1
6
1
0
0
4
0
0
Cash Equivalents
15 375
1 581
18 136
36 676
30 016
24 434
12 043
16 975
25 708
4 120
5 251
4 168
2 080
1 955
2 167
11 913
9 737
4 850
3 162
5 555
19 211
9 189
2 732
Short-Term Investments
7 172
22 526
35 427
31 113
32 853
41 172
2 147
18 085
3 368
2 129
99
100
0
0
0
0
3 000
0
0
1 500
0
13 010
16 000
Total Receivables
5 857
16 509
65 694
70 386
68 413
64 899
48 629
32 213
23 370
20 165
13 243
6 310
6 513
4 789
9 623
13 264
14 932
22 553
25 901
19 403
17 264
8 913
1 740
Accounts Receivables
5 286
14 724
64 352
68 041
65 856
62 170
46 774
31 255
22 698
19 217
12 732
4 325
6 019
4 400
8 632
11 938
13 162
19 433
22 446
18 164
11 236
7 671
1 324
Other Receivables
571
1 785
1 342
2 345
2 557
2 729
1 855
958
672
948
511
1 985
494
389
991
1 326
1 770
3 120
3 455
1 239
6 028
1 242
416
Inventory
12 298
7 712
46 278
67 365
51 867
56 690
24 290
19 207
24 272
22 529
23 741
13 103
10 318
9 111
6 835
5 509
6 664
5 876
4 175
6 080
4 215
3 350
2 946
Other Current Assets
323
1 175
4 923
7 295
8 358
9 377
5 599
8 856
2 779
2 550
1 889
932
1 419
4 656
3 525
3 434
3 343
3 089
2 454
731
1 166
389
593
Total Current Assets
41 024
49 503
170 457
212 834
191 506
196 573
92 710
95 337
79 497
51 492
44 223
24 613
20 330
20 514
22 151
34 122
37 682
36 368
35 692
33 269
41 860
34 851
24 012
PP&E Net
9 473
8 434
19 262
18 297
19 334
17 101
7 049
4 653
6 873
7 680
6 701
5 145
7 169
5 709
5 707
5 418
10 081
9 437
8 370
7 196
6 674
6 073
6 376
PP&E Gross
9 473
8 434
19 262
18 297
19 334
17 101
7 049
4 653
6 873
7 680
6 701
5 145
7 169
5 709
5 707
5 418
10 081
9 437
8 370
7 196
6 674
6 073
6 376
Accumulated Depreciation
826
2 832
9 026
14 489
12 456
14 279
6 948
9 639
11 399
11 013
13 000
11 007
12 450
12 098
12 882
13 304
14 277
15 615
17 084
18 783
19 930
21 356
15 669
Intangible Assets
1 458
4 205
5 002
5 560
6 789
7 137
2 324
2 480
175
51
706
388
907
945
1 012
625
2 220
1 852
8 483
19 409
39 395
33 664
33 175
Goodwill
3 723
3 336
2 366
2 196
2 027
1 789
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
184
305
113
99
183
523
196
47
192
49
2
0
0
0
0
0
0
40
40
531
61
81
1 027
Long-Term Investments
8 142
8 851
393
1 015
1 373
4 922
2 978
451
538
154
0
0
54
104
600
600
773
572
1 156
1 974
3 446
4 930
1 469
Other Long-Term Assets
193
1 271
3 007
2 551
3 588
2 790
259
197
250
1 759
361
326
3 602
3 571
3 337
2 649
2 625
1 231
268
856
877
929
1 268
Other Assets
3 723
3 336
2 366
2 196
2 027
1 789
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
64 197
N/A
75 904
+18%
200 600
+164%
242 552
+21%
224 800
-7%
230 835
+3%
105 516
-54%
103 164
-2%
87 526
-15%
61 186
-30%
51 993
-15%
30 472
-41%
32 061
+5%
30 843
-4%
32 807
+6%
43 414
+32%
53 381
+23%
49 499
-7%
54 008
+9%
63 236
+17%
92 311
+46%
80 528
-13%
67 327
-16%
Liabilities
Accounts Payable
22 866
25 764
21 047
26 071
25 819
18 242
43 361
7 769
4 635
8 950
5 179
2 759
2 271
2 028
3 692
2 845
3 454
604
390
828
178
192
687
Accrued Liabilities
253
278
1 342
1 922
274
1 473
4 751
1 089
1 024
777
1 176
2 141
724
460
472
833
2 311
810
854
172
144
124
141
Short-Term Debt
565
0
107 744
136 264
125 677
139 745
53 760
0
0
6 500
9 551
7 185
7 554
5 043
4 900
4 900
8 327
7 033
4 400
4 400
6 400
6 400
5 900
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
164
0
0
0
11 977
9 345
3 224
7 988
1 203
8 802
307
Other Current Liabilities
4 775
4 253
5 916
9 469
11 411
10 946
43 588
9 978
10 778
5 331
2 859
3 693
1 814
1 191
882
1 130
1 834
690
2 569
559
1 043
1 135
1 349
Total Current Liabilities
28 459
30 295
136 048
173 726
163 180
170 406
145 459
18 836
16 438
21 558
18 766
15 779
12 526
8 721
9 945
9 707
27 904
18 482
11 437
13 947
8 968
16 652
8 384
Long-Term Debt
0
0
0
0
0
20 362
0
25 612
20 201
0
815
144
0
0
0
8 469
7 014
0
1 644
1 086
29 535
286
42
Deferred Income Tax
903
1 485
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
168
233
1 758
1 296
0
Other Liabilities
266
286
468
481
676
741
604
473
528
329
706
374
638
318
376
633
249
114
275
980
827
723
666
Total Liabilities
29 629
N/A
32 066
+8%
136 516
+326%
174 207
+28%
163 857
-6%
191 508
+17%
146 064
-24%
44 920
-69%
37 166
-17%
21 886
-41%
20 287
-7%
16 297
-20%
13 164
-19%
9 039
-31%
10 322
+14%
18 809
+82%
35 167
+87%
18 608
-47%
13 524
-27%
16 246
+20%
41 089
+153%
18 957
-54%
9 091
-52%
Equity
Common Stock
30 000
30 000
42 860
42 860
42 860
45 477
55 968
46 896
48 347
48 355
49 361
5 017
10 234
14 860
15 149
15 149
15 149
16 287
16 859
17 323
82 275
115 689
129 399
Retained Earnings
3 691
12 471
7 124
11 969
5 204
23 211
122 362
122 279
120 306
13 557
21 827
38 764
46 721
57 074
60 182
59 471
67 541
66 323
63 705
62 938
71 545
90 481
106 288
Additional Paid In Capital
0
0
23 036
23 033
23 033
25 912
33 690
132 679
138 476
18 202
18 394
63 428
69 678
77 204
78 913
80 313
81 727
92 008
98 352
103 645
51 608
46 311
45 181
Unrealized Security Profit/Loss
976
1 416
0
0
0
0
825
1 847
2 664
1 848
51
71
331
33
54
44
196
333
356
307
120
166
423
Treasury Stock
0
0
9 228
9 371
9 371
9 371
9 371
9 371
9 371
0
0
4
4
4
4
4
4
4
4
4
4
4
4
Other Equity
99
49
292
145
782
518
2 352
8 473
4 122
11 852
14 172
15 432
13 960
13 150
11 337
11 337
11 312
11 410
11 374
11 343
11 232
10 109
10 476
Total Equity
34 569
N/A
43 839
+27%
64 084
+46%
68 345
+7%
60 943
-11%
39 326
-35%
40 548
N/A
58 244
N/A
50 359
-14%
39 300
-22%
31 706
-19%
14 175
-55%
18 896
+33%
21 804
+15%
22 485
+3%
24 605
+9%
18 215
-26%
30 891
+70%
40 484
+31%
46 990
+16%
51 223
+9%
61 571
+20%
58 235
-5%
Total Liabilities & Equity
64 197
N/A
75 904
+18%
200 600
+164%
242 552
+21%
224 800
-7%
230 835
+3%
105 516
-54%
103 164
-2%
87 526
-15%
61 186
-30%
51 993
-15%
30 472
-41%
32 061
+5%
30 843
-4%
32 807
+6%
43 414
+32%
53 381
+23%
49 499
-7%
54 008
+9%
63 236
+17%
92 311
+46%
80 528
-13%
67 327
-16%
Shares Outstanding
Common Shares Outstanding
0
0
1
1
1
1
1
21
22
22
23
23
47
63
64
64
64
69
72
74
76
82
84